Optimizing strategies for population-based chlamydia infection screening among young women: an age-structured system dynamics approach

[1]  Albert Y. Zomaya,et al.  Partial Differential Equations , 2007, Explorations in Numerical Analysis.

[2]  Wanzhu Tu,et al.  Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model , 2014, Journal of Clinical Bioinformatics.

[3]  Wanzhu Tu,et al.  Optimizing coverage for a Chlamydia trachomatis screening program , 2011, 2011 IEEE International Conference on Automation Science and Engineering.

[4]  N. Low,et al.  Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. , 2010, Epidemics.

[5]  Robert E. Johnson,et al.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. , 2010, The Journal of infectious diseases.

[6]  Richard White,et al.  An Introduction to Infectious Disease Modelling , 2010 .

[7]  J. Fortenberry,et al.  Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women. , 2009, Archives of pediatrics & adolescent medicine.

[8]  O. Sharomi,et al.  Re-infection-induced backward bifurcation in the transmission dynamics of Chlamydia trachomatis , 2009 .

[9]  N. Low,et al.  Effectiveness of chlamydia screening: systematic review. , 2009, International journal of epidemiology.

[10]  David P Wilson,et al.  Coverage is the key for effective screening of Chlamydia trachomatis in Australia. , 2008, The Journal of infectious diseases.

[11]  M. Keeling,et al.  Modeling Infectious Diseases in Humans and Animals , 2007 .

[12]  Robert E. Johnson,et al.  Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002 , 2007, Annals of Internal Medicine.

[13]  P. Manfredi,et al.  Vaccinating behaviour, information, and the dynamics of SIR vaccine preventable diseases. , 2007, Theoretical population biology.

[14]  J. Sterne,et al.  Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. , 2007, Health technology assessment.

[15]  M. Connock,et al.  Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. , 2007, Health technology assessment.

[16]  S. Goldie,et al.  The Impact of Natural History Parameters on the Cost-Effectiveness of Chlamydia trachomatis Screening Strategies , 2006, Sexually transmitted diseases.

[17]  A. Edwards.  Screening in disease prevention: What works? , 2006, Quality and Safety in Health Care.

[18]  P Barton,et al.  Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling , 2006, Sexually Transmitted Infections.

[19]  B. Van Der Pol,et al.  Use of an Adaptation of a Commercially Available PCR Assay Aimed at Diagnosis of Chlamydia and Gonorrhea To Detect Trichomonas vaginalis in Urogenital Specimens , 2006, Journal of Clinical Microbiology.

[20]  W. Holland,et al.  Screening in Disease Prevention: What Works? , 2005 .

[21]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[22]  S. Goldie,et al.  Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis , 2004, Annals of Internal Medicine.

[23]  C. Lau,et al.  Azithromycin Versus Doxycycline for Genital Chlamydial Infections: A Meta-Analysis of Randomized Clinical Trials , 2002, Sexually transmitted diseases.

[24]  Charlotte Gaydos,et al.  Screening for Chlamydia trachomatis in Asymptomatic Women Attending Family Planning Clinics: A Cost-Effectiveness Analysis of Three Strategies , 1998, Annals of Internal Medicine.

[25]  A. Viera,et al.  Pelvic inflammatory disease , 1996, Springer New York.

[26]  B. Katz,et al.  Age and Clinical Immunity to Infections With Chlamydia trachomatis , 1994, Sexually transmitted diseases.

[27]  K. Hillman,et al.  Infections of the Central Nervous System , 1992, Neurology.

[28]  D. Fine,et al.  STDs and family planning clinics: a regional program for Chlamydia control that works. , 1992, The American journal of gynecologic health.

[29]  W. Cates,et al.  Genital chlamydial infections: epidemiology and reproductive sequelae. , 1991, American journal of obstetrics and gynecology.

[30]  F. Skjeldestad,et al.  Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? , 1990, The British journal of general practice : the journal of the Royal College of General Practitioners.

[31]  F. Skjeldestad,et al.  [Chlamydia trachomatis in cervix uteri specimens among patients in general practice]. , 1988, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[32]  James Mcsherry.  Sexually transmitted disease surveillance. , 1982, British medical journal.

[33]  N. Ling.  The Mathematical Theory of Infectious Diseases and its applications , 1978 .

[34]  Elizabeth A Torrone,et al.  Reported STDs in the United States : 2012 national data for chlamydia, gonorrhea, and syphilis , 2014 .

[35]  Emilia Vynnycky,et al.  Comprar An Introduction to Infectious Disease Modelling | Emilia Vynnycky | 9780198565765 | Oxford University Press , 2010 .

[36]  J. Stockman.  Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age , 2007, Annals of Internal Medicine.

[37]  S. Hammer.  INTRODUCTION TO INFECTIOUS DISEASE , 2004 .

[38]  M. Kretzschmar,et al.  Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. , 2001, American journal of epidemiology.

[39]  J C Jager,et al.  Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. , 2000, Sexually transmitted diseases.

[40]  L. Allen,et al.  An analysis of the transmission of chlamydia in a closed population , 1996 .

[41]  Alexander Grey,et al.  The Mathematical Theory of Infectious Diseases and Its Applications , 1977 .